New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release.

Insight That Drives Action

New Peer-Reviewed Evidence Confirms the MSDA Test’s Impact on Clinical Decisions in MS Care.

The Octave® MSDA Test

The MSDA Test is the first and only multi-analyte biomarker blood test developed specifically to measure MS disease activity.

Detailed, personalized reporting empowers patients and providers to make care decisions with confidence.

Clinical decisions based on objective biomarkers

Providers

Informing Decision Points
Incorporating the Octave MSDA test adds new insights to consider when making treatment choices.

Patients

Your MS, Unlocked
Multiple sclerosis is clouded with uncertainty. Your Octave MSDA test results provide data-driven insights to measure your disease activity level.

The Key to the Future of Precision Medicine

Personalized insights for neurodegenerative diseases can transform care across a range of clinical scenarios.

IN DEVELOPMENT

MS DIsease Activity

IN DEVELOPMENT

MS Disease Progression

Parkinson's Disease